A. Norman

16.8k total citations · 3 hit papers
138 papers, 12.3k citations indexed

About

A. Norman is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Norman has authored 138 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Surgery, 63 papers in Oncology and 55 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Norman's work include Colorectal Cancer Treatments and Studies (26 papers), Colorectal and Anal Carcinomas (21 papers) and Gastric Cancer Management and Outcomes (21 papers). A. Norman is often cited by papers focused on Colorectal Cancer Treatments and Studies (26 papers), Colorectal and Anal Carcinomas (21 papers) and Gastric Cancer Management and Outcomes (21 papers). A. Norman collaborates with scholars based in United Kingdom, United States and Australia. A. Norman's co-authors include David Cunningham, David P. Dearnaley, Timothy Iveson, M. Nicolson, Robert Huddart, J. Oates, Sheela Rao, Gina Brown, Diana Tait and Gary Middleton and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

A. Norman

137 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

2008 1.7k citations David Cunningham, Timothy Iveson et al. profile →
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1997 691 citations David Cunningham, Peter Harper et al. profile →
Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1999 536 citations David P. Dearnaley, Vincent Khoo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Norman United Kingdom	58	5.9k	5.9k	5.2k	1.6k	1.2k	138	12.3k
Christian Wittekind Germany	59	10.7k 1.8×	4.5k 0.8×	9.4k 1.8×	1.4k 0.8×	2.3k 1.9×	218	17.3k
Joel E. Tepper United States	65	8.1k 1.4×	6.9k 1.2×	6.5k 1.3×	1.2k 0.7×	1.3k 1.1×	247	14.5k
Leonard L. Gunderson United States	66	11.6k 2.0×	10.5k 1.8×	13.7k 2.6×	1.2k 0.7×	705 0.6×	218	20.6k
Herman R. Menck United States	59	5.7k 1.0×	4.0k 0.7×	4.4k 0.8×	592 0.4×	1.8k 1.5×	131	13.1k
Prajnan Das United States	48	6.0k 1.0×	3.5k 0.6×	5.6k 1.1×	1.2k 0.7×	542 0.5×	323	9.8k
Lars Påhlman Sweden	67	18.8k 3.2×	4.8k 0.8×	15.3k 2.9×	1.3k 0.8×	735 0.6×	283	22.8k
Dirk Arnold Germany	47	11.4k 1.9×	6.7k 1.1×	6.9k 1.3×	1.3k 0.8×	1.6k 1.3×	271	17.0k
Charles Catton Canada	63	4.7k 0.8×	10.9k 1.9×	4.3k 0.8×	1.9k 1.1×	516 0.4×	328	14.3k
Cornelis Verhoef Netherlands	53	6.1k 1.0×	3.1k 0.5×	3.3k 0.6×	998 0.6×	1.4k 1.2×	476	11.0k
José G. Guillem United States	80	15.3k 2.6×	4.2k 0.7×	11.1k 2.1×	1.2k 0.8×	877 0.7×	301	18.8k

Countries citing papers authored by A. Norman

Since Specialization

Citations

This map shows the geographic impact of A. Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Norman more than expected).

Fields of papers citing papers by A. Norman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Norman. The network helps show where A. Norman may publish in the future.

Co-authorship network of co-authors of A. Norman

This figure shows the co-authorship network connecting the top 25 collaborators of A. Norman. A scholar is included among the top collaborators of A. Norman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Norman. A. Norman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moynihan, Katie M., et al.. (2021). Pediatric Thromboelastograph 6s and Laboratory Coagulation Reference Values. Archives of Pathology & Laboratory Medicine. 145(11). 1413–1423. 6 indexed citations

Urbano, Teresa Guerrero, Vincent Khoo, J. Staffurth, et al.. (2010). Intensity-modulated Radiotherapy Allows Escalation of the Radiation Dose to the Pelvic Lymph Nodes in Patients with Locally Advanced Prostate Cancer: Preliminary Results of a Phase I Dose Escalation Study. Clinical Oncology. 22(3). 236–244. 31 indexed citations

Okines, Alicia, A. Norman, P. McCloud, Yoon‐Koo Kang, & David Cunningham. (2009). Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Annals of Oncology. 20(9). 1529–1534. 176 indexed citations

Chau, Ian, A. Norman, David Cunningham, et al.. (2009). The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials. Annals of Oncology. 20(5). 885–891. 40 indexed citations

Venkitaraman, Ramachandran, A. Norman, David P. Dearnaley, et al.. (2008). Clinical implications of introducing a new PSA assay. International Urology and Nephrology. 40(3). 657–661. 5 indexed citations

Burton, Sarah, Gina Brown, Nicola Bees, et al.. (2007). Accuracy of CT prediction of poor prognostic features in colonic cancer. British Journal of Radiology. 81(961). 10–19. 67 indexed citations

Koh, Dow‐Mu, et al.. (2007). Diagnostic Accuracy of Rim and Segmental MRI Enhancement of Colorectal Hepatic Metastasis After Administration of Mangafodipir Trisodium. American Journal of Roentgenology. 188(2). W154–W161. 12 indexed citations

Koh, Dow‐Mu, Erica Scurr, David J. Collins, et al.. (2007). Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients. American Journal of Roentgenology. 188(4). 1001–1008. 283 indexed citations

Arkenau, Hendrik‐Tobias, Geoffrey Chong, David Cunningham, et al.. (2006). The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Annals of Oncology. 18(3). 541–545. 63 indexed citations

10.

Burton, Sarah, et al.. (2006). MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. British Journal of Cancer. 94(3). 351–357. 211 indexed citations

11.

Huddart, Robert, A. Norman, Clare Moynihan, et al.. (2005). Fertility, gonadal and sexual function in survivors of testicular cancer. British Journal of Cancer. 93(2). 200–207. 208 indexed citations

12.

Andreyev, Jervoise, Panagiotis Vlavianos, Peter Blake, et al.. (2005). Gastrointestinal symptoms after pelvic radiotherapy: Role for the gastroenterologist?. International Journal of Radiation Oncology*Biology*Physics. 62(5). 1464–1471. 103 indexed citations

13.

Koh, Dow‐Mu, Gina Brown, Louis Temple, et al.. (2004). Rectal Cancer: Mesorectal Lymph Nodes at MR Imaging with USPIO versus Histopathologic Findings—Initial Observations. Radiology. 231(1). 91–99. 191 indexed citations

14.

O’Sullivan, Joe M., A. Norman, H. McNair, & David P. Dearnaley. (2004). Cranial nerve palsies in metastatic prostate cancer—results of base of skull radiotherapy. Radiotherapy and Oncology. 70(1). 87–90. 14 indexed citations

15.

McNair, H., Chris Parker, Vibeke N. Hansen, et al.. (2004). An Evaluation of Beam Cath®in the Verification Process for Prostate Cancer Radiotherapy. Clinical Oncology. 16(2). 138–147. 5 indexed citations

16.

HENDRY, W. F., A. Norman, David P. Dearnaley, et al.. (2002). Metastatic nonseminomatous germ cell tumors of the testis. Cancer. 94(6). 1668–1676. 107 indexed citations

17.

Shahidi, Mehdi, A. Norman, David P. Dearnaley, et al.. (2002). Late recurrence in 1263 men with testicular germ cell tumors. Cancer. 95(3). 520–530. 86 indexed citations

18.

HENDRY, W. F., A. Norman, J. Nicholls, et al.. (2000). Abdominal relapse in stage 1 nonseminomatous germ cell tumours of the testis managed by surveillance or with adjuvant chemotherapy. British Journal of Urology. 86(1). 89–93. 15 indexed citations

19.

Nutting, Christopher M., Vincent Khoo, H. McNair, et al.. (2000). A randomised study of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy. Radiotherapy and Oncology. 54(1). 1–9. 40 indexed citations

20.

Andreyev, Jervoise, Anne Rigg, David Cunningham, et al.. (1995). 560 Infusional 5-fluorouracil with alpha interferon as a palliative treatment for patients with symptomatic malignant neuroendocrine tumours. European Journal of Cancer. 31. S119–S119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact